 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 July 2000 | Volume 133 Issue 2 | Pages 81-91
Background: Major risk factors explain much of the excess risk for coronary heart disease produced by diabetes, but nontraditional factors may also relate to incident coronary heart disease.
Objective: To examine the association of traditional and nontraditional risk factors with incidence of coronary heart disease in adults with diabetes.
Design: Prospective cohort study.
Setting: The Atherosclerosis Risk in Communities (ARIC) Study.
Participants: 1676 middle-aged persons who had diabetes but no history of prevalent coronary heart disease.
Measurements: Multiple risk factors were recorded at baseline. Follow-up was from 1987 through 1995.
Results: 186 participants developed incident coronary heart disease events during follow-up. As expected, the incidence of coronary heart disease in participants with diabetes was associated positively with traditional risk factors (hypertension, smoking, total cholesterol level, and low high-density lipoprotein [HDL] cholesterol level). After adjustment for sex, age, ethnicity, and ARIC field center, incident coronary heart disease was also significantly associated with waist-to-hip ratio; levels of HDL3 cholesterol, apolipoproteins A-I and B, albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count. However, after adjustment for traditional risk factors for coronary heart disease, only levels of albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count remained independently associated with coronary heart disease (P < 0.03). The relative risks associated with the highest compared with lowest groupings of albumin, fibrinogen, factor VIII, and von Willebrand factor values and leukocyte count were 0.64 (95% CI, 0.44 to 0.92), 1.75 (CI, 1.12 to 2.73), 1.58 (CI, 1.02 to 2.42), 1.71 (CI, 1.11 to 2.63), and 1.90 (CI, 1.16 to 3.13), respectively. Adjustment for diabetes treatment status attenuated these associations somewhat.
Conclusions: Levels of albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count were predictors of coronary heart disease among persons with diabetes. These associations may reflect 1) the underlying inflammatory reaction or microvascular injury related to atherosclerosis and a tendency toward thrombosis or 2) common antecedents for both diabetes and coronary heart disease.
Author and Article Information
From Oita Medical University, Oita, Japan; School of Public Health, University of Minnesota, Minneapolis, Minnesota; Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, Maryland; School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil; and University of North Carolina, Chapel Hill, North Carolina.
Acknowledgments: The authors thank Ms. Lori Boland and Ms. Laura Kemmis for technical assistance and all ARIC staff and participants for their valuable contributions.
Grant Support: The ARIC study is supported by contracts N01-HC-55015, N01-HC-55016, N01-HC 55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022 from the National Heart, Lung and Blood Institute. Dr. Brancati was supported by an Established Investigator Grant from the American Heart Association, Dallas, Texas.
Requests for Single Reprints: Aaron R. Folsom, MD, Division of Epidemiology, School of Public Health, University of Minnesota, Suite 300, 1300 South Second Street, Minneapolis, MN 55454-1015; e-mail, folsom{at}epi.umn.edu.
Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.
Current Author Addresses: Dr. Saito: Department of Public Health and Hygiene, Oita Medical University, 1-1 Idaigaoka, Hasama-machi, Oita 879-5593, Japan.
Drs. Folsom and McGovern: Division of Epidemiology, School of Public Health, University of Minnesota, Suite 300, 1300 South Second Street, Minneapolis, MN 55454-1015.
Dr. Brancati: Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical Institutions, 2024 East Monument Street, Suite 2-619, Baltimore, MD 21205.
Dr. Duncan: Department of Social Medicine, School of Medicine, Universidade Federal de Rio Grande, R. Ramiro Barcelos 2600/414, Porto Alegre, RS, Brazil.
Dr. Chambless: Department of Biostatistics, University of North Carolina, 137 East Franklin Street, Suite 203, Chapel Hill, NC 27514.
Author Contributions: Conception and design: I. Saito, A.R. Folsom, B.B. Duncan.
Critical revision of the article for important intellectual content: I. Saito, A.R. Folsom, F.L. Brancati, B.B. Duncan, L.E. Chambless, P.G. McGovern.
Final approval of the article: I. Saito, A.R. Folsom, F.L. Brancati, B.B. Duncan, L.E. Chambless, P.G. McGovern.
Provision of study materials or patients: I. Saito, A.R. Folsom, L.E. Chambless.
Statistical expertise: L.E. Chambless, P.G. McGovern.
Obtaining of funding: I. Saito, A.R. Folsom.
Collection and assembly of data: I. Saito, A.R. Folsom. ARTICLE
Nontraditional Risk Factors for Coronary Heart Disease Incidence among Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  C.-H. Tseng Exogenous Insulin Use and Hypertension in Adult Patients With Type 2 Diabetes Mellitus. Arch Intern Med, June 12, 2006; 166(11): 1184 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Folsom, G. W. Evans, J. J. Carr, A. E. Stillman, and Atherosclerosis Risk in Communities (ARIC) Study I Association of Traditional and Nontraditional Cardiovascular Risk Factors with Coronary Artery Calcification Angiology, November 1, 2004; 55(6): 613 - 623. [Abstract] [PDF]
|
|
|
|
 |
|
 O. C. Marroquin, K. E. Kip, D. E. Kelley, B. D. Johnson, L. J. Shaw, C. N. Bairey Merz, B. L. Sharaf, C. J. Pepine, G. Sopko, S. E. Reis, et al. Metabolic Syndrome Modifies the Cardiovascular Risk Associated With Angiographic Coronary Artery Disease in Women: A Report From the Women's Ischemia Syndrome Evaluation Circulation, February 17, 2004; 109(6): 714 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes Endocr. Rev., February 1, 2004; 25(1): 153 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Tong, K.-F. Lee, W.-Y. So, M. H. Ng, W.-B. Chan, M. K. Lo, N. N. Chan, and J. C. Chan White Blood Cell Count Is Associated With Macro- and Microvascular Complications in Chinese Patients With Type 2 Diabetes Diabetes Care, January 1, 2004; 27(1): 216 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Reilly and D. J. Rader The Metabolic Syndrome: More Than the Sum of Its Parts? Circulation, September 30, 2003; 108(13): 1546 - 1551. [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Batty, M. J. Shipley, M. G. Marmot, and G. Davey Smith Leisure Time Physical Activity and Disease-Specific Mortality Among Men With Chronic Bronchitis: Evidence From the Whitehall Study Am J Public Health, May 1, 2003; 93(5): 817 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Engstrom, L. Stavenow, B. Hedblad, P. Lind, K.-F. Eriksson, L. Janzon, and F. Lindgarde Inflammation-Sensitive Plasma Proteins, Diabetes, and Mortality and Incidence of Myocardial Infarction and Stroke: A Population-Based Study Diabetes, February 1, 2003; 52(2): 442 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.H. Whincup, J. Danesh, M. Walker, L. Lennon, A. Thomson, P. Appleby, A. Rumley, and G.D.O. Lowe von Willebrand factor and coronary heart disease. Prospective study and meta-analysis Eur. Heart J., November 2, 2002; 23(22): 1764 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Viberti, S. E. Kahn, D. A. Greene, W. H. Herman, B. Zinman, R. R. Holman, S. M. Haffner, D. Levy, J. M. Lachin, R. A. Berry, et al. A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes Diabetes Care, October 1, 2002; 25(10): 1737 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E.K. Klein, R. Klein, and K. E. Lee Components of the Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes in Beaver Dam Diabetes Care, October 1, 2002; 25(10): 1790 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Haffner, A. S. Greenberg, W. M. Weston, H. Chen, K. Williams, and M. I. Freed Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus Circulation, August 6, 2002; 106(6): 679 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Meininger, C. Hadigan, P. Rietschel, and S. Grinspoon Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men Am. J. Clinical Nutrition, August 1, 2002; 76(2): 460 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.A. Szczech, P.J. Best, E. Crowley, M.M. Brooks, P.B. Berger, V. Bittner, B.J. Gersh, R. Jones, R.M. Califf, H.H. Ting, et al. Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation Circulation, May 14, 2002; 105(19): 2253 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Redberg, P. Greenland, V. Fuster, K. Pyorala, S. N. Blair, A. R. Folsom, A. B. Newman, D. H. O'Leary, T. J. Orchard, B. Psaty, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: Risk Assessment in Persons With Diabetes Circulation, May 7, 2002; 105 (18): e144 - e152. [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus Clin. Chem., March 1, 2002; 48(3): 436 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Sharrett, C. M. Ballantyne, S. A. Coady, G. Heiss, P. D. Sorlie, D. Catellier, and W. Patsch Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study Circulation, September 4, 2001; 104(10): 1108 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Nichols, T. A. Hillier, J. R. Erbey, and J. B. Brown Congestive Heart Failure in Type 2 Diabetes: Prevalence, incidence, and risk factors Diabetes Care, September 1, 2001; 24(9): 1614 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Crouse III and C. D. Furberg Treatment of Dyslipidemia : Room for Improvement? Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2333 - 2335. [Full Text] [PDF]
|
|
|
|
 |
|
 Nontraditional CHD Risk Factors in Diabetics Journal Watch Cardiology, September 29, 2000; 2000(929): 4 - 4. [Full Text]
|
|
|
|
 |
|
 New Risk Factors for Heart Disease in Diabetics? Journal Watch (General), August 8, 2000; 2000(808): 3 - 3. [Full Text]
|
|
|
|
 |
|
 V. A. Fonseca Risk Factors for Coronary Heart Disease in Diabetes Ann Intern Med, July 18, 2000; 133(2): 154 - 156. [Full Text] [PDF]
|
|
Article
